A Patient Power Team Member Shares Her Clinical Trial Experience

Published on

Topics include: Patient Stories

Email this program

Get Link

Live on location at the Dana-Faber Cancer Institute, Patient Power PR Contributor and CLL patient Michele Nadeem-Baker takes us inside the infusion room where she is currently undergoing treatment.  She is participating in the first-ever clinical trial where ibrutinib (Imbuvica) is combined with FCR to achieve MRD negativity (total cure).  Michele explains the parameters of this Phase II trial and shares her personal insights as a patient.  Listen for Michele’s challenge as she encourages all cancer patients to “Be brave and bold.”

View more programs featuring

Related Programs

A Patient Power Team Member's Clinical Trial Video Diary: Month 2

Patient Power contributor Michele Nadeem, on location at the Dana-Faber Cancer Institute, shares a video health update as she enters month two of the clinical trial she is participating in.

Published:

Michele Nadeem-Baker's Video Blog: Month 3

Patient Power contributor and CLL patient, Michele Nadeem-Baker, blogs about her FCR/ibrutinib combination therapy clinical trial at Dana-Farber Cancer Institute.

Published:

Featured Blog
Ms. Pollyanna, Meet Mr. Negativity

By C.J. Chris


Page last updated on June 16, 2016